Rhaeos
Rhaeos is a clinical-stage company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin sensor that can assess fluid flow peripherally throughout the body in and outside of the hospital. The company is initially targeting hydrocephalus, a condition caused by an abnormal accumulation of cerebrospinal fluid (CSF).
Contact Name:
Anna Lisa Somera
Contact Email:
Website:
https://www.rhaeos.com/
City, State – Congressional District:
Evanston,
IL
–
9
Technology:
Diagnostic
Funding:
Aging (NIA),
Neurological Disorders and Stroke (NINDS)
NIH Projects:
NIH RePorter for
Rhaeos
Sponsored Event(s):
RESI | 2025
,
HLTH | 2023
